WallachBeth Capital announced that bioAffinity Technologies (BIAF) priced a best efforts offering of securities for aggregate gross proceeds to the company of $3.25M, before deducting agent fees and other estimated expenses payable by the company. The offering consists of 10.16M shares of common stock together with warrants to initially purchase up to 15.23M shares of common stock. The combined public offering price for each share of common stock and accompanying warrant is 32c. The closing of the offering is expected to occur on or about May 7, subject to the satisfaction of customary closing conditions. WallachBeth Capital is acting as sole placement agent for the offering.

Protect Your Portfolio Against Market Uncertainty

Discover companies with rock-solid fundamentals in  TipRanks' Smart Value Newsletter. Receive undervalued stocks, resilient to market uncertainty,  delivered straight to your inbox.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

See Insiders’ Hot Stocks on TipRanks >>

Read More on BIAF:

Disclaimer & DisclosureReport an Issue

BioAffinity Technologies files to sell 7.01M shares of common stock, warrants bioAffinity Technologies Board Member Announces Departure bioAffinity Technologies Reports Record Revenue for 2024 BioAffinity Technologies downgraded to Hold from Buy at Maxim BIAF Upcoming Earnings Report: What to Expect?

View Comments